BSE Live
Jan 07, 15:13Prev. Close
33.51
Open Price
35.18
Bid Price (Qty.)
35.18 (204559)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 07, 15:15Prev. Close
33.42
Open Price
34.90
Bid Price (Qty.)
35.09 (756987)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Mangalam Drugs & Organics (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 4.99 | -11.06 | 2.21 | 27.73 | 39.52 | |
| Net CashFlow From Operating Activities | 42.76 | 12.17 | 39.52 | 25.71 | 27.55 | |
| Net Cash Used In Investing Activities | -19.47 | -17.91 | -22.17 | -27.33 | -31.29 | |
| Net Cash Used From Financing Activities | -21.71 | 5.70 | -16.62 | 2.98 | 2.70 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 1.57 | -0.04 | 0.73 | 1.36 | -1.04 | |
| Cash And Cash Equivalents Begin of Year | 1.00 | 1.04 | 1.95 | 0.58 | 1.63 | |
| Cash And Cash Equivalents End Of Year | 2.57 | 1.00 | 2.68 | 1.95 | 0.59 |
25.11.2025
Mangalam Drugs Consolidated September 2025 Net Sales at Rs 49.54 crore, down 38.03% Y-o-Y
24.11.2025
Mangalam Drugs Standalone September 2025 Net Sales at Rs 49.54 crore, down 38.03% Y-o-Y
22.08.2025
Mangalam Drugs Standalone June 2025 Net Sales at Rs 57.35 crore, down 25.07% Y-o-Y
19.05.2025
Mangalam Drugs Standalone March 2025 Net Sales at Rs 73.04 crore, down 28.56% Y-o-Y